@johndprent I'm interested in the apparent about-face you seem to have had regarding ex-director selling.
Of all of us here during the BG sell-down days, you were one of the few (maybe only?) one who seemed to be consistently of the opinion that BG's selling was not something that was materially impacting the share price and that it was just a distraction. In hindsight, I think you were proven correct, as RAC's share price really started collapsing just after BG was off the register, although this unfortunately coincided with Dr T departing and the internal chaos within RAC becoming externally visible, so it wasn't the only factor at that time perhaps.
Fortunate timing for BG, or was there so much expectation of a huge rally once that supply (which was being religiously tracked on an almost daily basis) dried up that the market did what it does and that was the exact opposite of what the expectation was. Perhaps people were buying hoping to secure some of BG's last 'cheap' shares and once they were gone that demand disappeared. Who knows?
Anyway, reading between the lines it seems you feel differently about JC's selling/potential selling and are now one of the few that has been consistently raising it as an ongoing concern about the impact or potential impact it might have/is having. Am I interpreting things correctly and can you explain the difference in opinion between BGs and JCs selling if so?
PS. At least part of me wonders whether we have the opposite situation to BG selling now, where there is an expectation of JC's selling causing an ongoing major collapse in the share price and perhaps (the market again doing what it does) consequently RAC can rally into that wall of worry.
- Forums
- ASX - By Stock
- RAC
- RAC - Charts & Price Action
RAC
race oncology ltd
Add to My Watchlist
3.38%
!
$1.15

RAC - Charts & Price Action, page-19247
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
-0.040(3.38%) |
Mkt cap ! $198.9M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.13 | $132.0K | 114.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2390 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 4805 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2390 | 1.140 |
3 | 5274 | 1.135 |
4 | 7220 | 1.130 |
1 | 2008 | 1.125 |
5 | 14965 | 1.120 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 4805 | 1 |
1.205 | 2500 | 1 |
1.220 | 21445 | 4 |
1.230 | 7500 | 2 |
1.245 | 2000 | 1 |
Last trade - 15.57pm 04/07/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online